Search
Search Constraints
You searched for: Author/Creator Todesco, SLimit your search
- Todesco, S [remove] 12
- 616.723005 12
- Rheumatism -- Periodicals 12
- ACR, American College of Rheumatology -- ANA, antinuclear antibody -- CRP, C reactive protein -- DAS, disease activity score -- DMARDs, disease modifying antirheumatic drugs -- ESR, erythrocyte sedimentation rate -- EULAR, European League Against Rheumatism -- HAQ DI, Disability Index of the Health Assessment Questionnaire -- MTX, methotrexate -- NSAIDs, non-steroidal anti-inflammatory drugs -- RA, rheumatoid arthritis -- TNF, tumour necrosis factor 1
- BMI, body mass index -- CRP, C reactive protein -- EOA, erosive osteoarthritis -- ESR, erythrocyte sedimentation rate -- hsCRP, high sensitivity CRP -- IL, interleukin -- JC, joint count -- OA, osteoarthritis -- RS, radiographic score 1
- C reactive protein -- osteoarthritis -- erosive osteoarthritis 1
- DMARD, disease modifying antirheumatic drug -- F/SI-PD, fluid/synovium interface power Doppler flow configuration -- GHS, global health status -- KJAI, knee joint articular index -- KJS, knee joint synovitis -- LPPR, lateral parapatellar recess -- MPPR, medial parapatellar recess -- P/CI-PD, pannus/cartilage interface power Doppler flow configuration -- RAI, Ritchie articular index -- SPR, suprapatellar recess -- TNFα, tumour necrosis factor α -- TNFR:Fc, tumour necrosis factor receptor–Fc dimeric fusion protein 1
- IL, interleukin -- IVIg, intravenous immunoglobulin -- TNF, tumour necrosis factor 1
- aCL, anticardiolipin antibody -- ACR, American College of Rheumatology -- aPL, antiphospholipid antibody -- β2GPI, β2-glycoprotein I -- BP, blood pressure -- CRP, C reactive protein -- CVD, cardiovascular disease -- ELISA, enzyme linked immunosorbent assay -- HSP 65, heat shock protein 65 -- IMT, intima-media thickness -- LA, lupus anticoagulant -- LDL, low density lipoprotein -- m-IMT, mean intima-media thickness -- M-IMT, maximum intima-media thickness -- oxPAPC, oxidised palmitoyl arachidonoyl phosphocholine -- SLE, systemic lupus erythematosus 1
- adalimumab -- disease modifying antirheumatic drugs -- human monoclonal antibodies -- monotherapy -- rheumatoid arthritis -- tumour necrosis factor α 1
- arthritis flare -- bosentan -- methotrexate -- scleroderma 1